Latasha Garrett
Psychiatric/Mental Health · Memphis, TNNPI 1962093765
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,673 and has fallen 93.1% since, to $255 in 2025. Among psychiatric/mental health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 345 payments — averaging $24.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Alkermes, Inc.$918
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$886
- Otsuka America Pharmaceutical, Inc.$875
- Neurocrine Biosciences, Inc.$523
- plus $3K from 20 others
What the payments were for
- Food & beverage$8,432100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,154 |
| Johnson & Johnson | 49 | $1,143 |
| Alkermes, Inc. | 26 | $918 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $886 |
| Otsuka America Pharmaceutical, Inc. | 39 | $875 |
| Neurocrine Biosciences, Inc. | 27 | $523 |
| Lundbeck LLC | 20 | $430 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $408 |
| Vanda Pharmaceuticals Inc. | 11 | $393 |
| Axsome Therapeutics, Inc. | 8 | $379 |
| Supernus Pharmaceuticals, Inc. | 9 | $339 |
| Idorsia Pharmaceuticals US Inc | 8 | $185 |
| Indivior Inc. | 9 | $160 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Sunovion Pharmaceuticals Inc. | 7 | $121 |
| Brainsway USA Inc | 2 | $102 |
| Hydrofera LLC | 2 | $62 |
| Corium, LLC | 4 | $56 |
| Bausch Health US, LLC | 2 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Neuronetics, Inc. | 1 | $20 |
| Janssen Products, LP | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$895
- ARISTADA$477
- CAPLYTA$471
- VRAYLAR$461
- Auvelity$244
- SPRAVATO$243
- Fanapt$217
- QELBREE$173
- COBENFY$125
- INVEGA SUSTENNA$125
- INVEGA TRINZA$125
- ABILIFY ASIMTUFII$122
- ABILIFY MAINTENA$122
- ARISTADA INITIO$119
- REXULTI$117
- QUVIVIQ$111
- NUEDEXTA$106
- INGREZZA$100
How this compares
$8,432 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Memphis
- Mary AllenMemphis$422K
- Sarah VogelfangerMemphis$94K
- Michael HobbsMemphis$23K
- Angela HammondMemphis$16K
- Kristen LockeMemphis$9K
- Lisa WilliamsMemphis$8K
- Kristin FitchpatricMemphis$8K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.